NCT05154240 A Phase 1, Evaluate the Safety, Tolerability, and Pharmacokinetics of INS018_055 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT05134727 Assess the Safety, Tolerability and Pharmacokinetics of AZD5055 Following Single and Multiple Ascending Doses in Healthy Participants Status COMPLETED Phase PHASE1
NCT05130970 Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE2
NCT05098717 End-expiratory Trans-pulmonary Pressure Guided PEEP Titration in Patients With Pulmonary Fibrosis and UIP Pattern Undergoing Mechanical Ventilation Status RECRUITING Phase N/A
NCT05052229 Inhaled Nitric Oxide (iNO) in Idiopathic Pulmonary Fibrosis (IPF). Status RECRUITING Phase EARLY_PHASE1
NCT05042219 Effects of Pulmonary Diseases and Their Treatment on Cardiac Function Status RECRUITING Phase N/A
NCT05032066 A Multicenter Trial to Evaluate the Efficacy, Safety and Tolerability of HZN-825 in Subjects With Idiopathic Pulmonary Fibrosis Status TERMINATED Phase PHASE2
NCT05022784 Adherence to Nintedanib Among Idiopathic Pulmonary Fibrosis Patients Status COMPLETED Phase N/A
NCT05022771 A First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of PMG1015 Status COMPLETED Phase PHASE1
NCT05016817 Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IPF Status RECRUITING Phase PHASE1
NCT04968574 A Study Evaluating the Safety and Efficacy of ENV-101 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE2
NCT04965298 Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole Status RECRUITING Phase PHASE3
NCT04931147 A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT04905693 Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease Status ENROLLING_BY_INVITATION Phase PHASE3